![National Medical Policy](http://s1.studyres.com/store/data/007999761_1-6be6f107f7d6b73933aaae60e6ba71d1-300x300.png)
National Medical Policy
... wavelengths of 924 and 975nm and classical curettage either alone, simultaneously or in combination for the treatment of axillary hyperhidrosis. A randomized prospective controlled trial was carried out on 100 patients divided into four groups, each with a different protocol: Laser alone at 975nm (g ...
... wavelengths of 924 and 975nm and classical curettage either alone, simultaneously or in combination for the treatment of axillary hyperhidrosis. A randomized prospective controlled trial was carried out on 100 patients divided into four groups, each with a different protocol: Laser alone at 975nm (g ...
Using Sequential, Multiple Assignment, Randomized Trial (SMART
... Bierman et al. 2006; Marlowe et al. 2008; McKay 2005). This approach is based on the notion that patients differ in their responses to interventions: in order for an intervention to be most effective, it should be individualized and repeatedly adapted over time to individual progress. An adaptive in ...
... Bierman et al. 2006; Marlowe et al. 2008; McKay 2005). This approach is based on the notion that patients differ in their responses to interventions: in order for an intervention to be most effective, it should be individualized and repeatedly adapted over time to individual progress. An adaptive in ...
Drug Treatment and Rehabilitation Improvement
... manual compiles evidence-based treatment improvement protocols (TIPs) developed by two U.S. bodies, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse (NIDA), which can be adapted to the treatment needs of Central Asia in a culturally appr ...
... manual compiles evidence-based treatment improvement protocols (TIPs) developed by two U.S. bodies, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse (NIDA), which can be adapted to the treatment needs of Central Asia in a culturally appr ...
Team players against headache: multidisciplinary treatment of
... system: ‘headaches attributed to head/neck trauma, cervicogenic headache, or headache or facial pain attributed to a disorder of the temporomandibular joint’ (ICHD-II) [3]. However, the combination of manual therapy and exercise produces greater improvements in pain, function, quality of life and pa ...
... system: ‘headaches attributed to head/neck trauma, cervicogenic headache, or headache or facial pain attributed to a disorder of the temporomandibular joint’ (ICHD-II) [3]. However, the combination of manual therapy and exercise produces greater improvements in pain, function, quality of life and pa ...
- Wiley Online Library
... Table 4 [32–39]. We must stress that the prognostic value of these markers is uncertain. ...
... Table 4 [32–39]. We must stress that the prognostic value of these markers is uncertain. ...
Immune Globulin - Capital Blue Cross
... Given the heterogeneous nature and relapsing-remitting course of many of the diseases for which intravenous immunoglobulin infusion (IVIg) has been investigated as therapy, randomized controlled trials (RCTs) are important for evaluating true benefit. However, in the case of rare disease, RCTs may b ...
... Given the heterogeneous nature and relapsing-remitting course of many of the diseases for which intravenous immunoglobulin infusion (IVIg) has been investigated as therapy, randomized controlled trials (RCTs) are important for evaluating true benefit. However, in the case of rare disease, RCTs may b ...
$doc.title
... emotional abuse. To explain these impressive re sults, she hypothesized that “the crucial compo nent of the EMD procedure is the repeated eyemovements while the memory is maintained in awareness” (Shapiro, 1989, p. 220). Shortly thereafter, Shapiro reconceptualized EMD in terms of “accelerated inf ...
... emotional abuse. To explain these impressive re sults, she hypothesized that “the crucial compo nent of the EMD procedure is the repeated eyemovements while the memory is maintained in awareness” (Shapiro, 1989, p. 220). Shortly thereafter, Shapiro reconceptualized EMD in terms of “accelerated inf ...
International Standards for the Treatment of Drug Use Disorders
... supported by the scientific evidence, and sometimes is not in line with human rights principles and is not voluntary. This is also true in otherwise highly developed countries where availability of evidence-based treatment programs is often insufficient. ...
... supported by the scientific evidence, and sometimes is not in line with human rights principles and is not voluntary. This is also true in otherwise highly developed countries where availability of evidence-based treatment programs is often insufficient. ...
Agonists for Sedation in Pediatric Critical Care: A Systematic Review
... of sedative drug efficacy (18). The reduction in opioid consumption is a conveniently captured outcome and widely reported throughout included studies. Yet, it does not address therapeutic advantage conferred by the administration of α2 agonists other than lessening exposure to other potentially har ...
... of sedative drug efficacy (18). The reduction in opioid consumption is a conveniently captured outcome and widely reported throughout included studies. Yet, it does not address therapeutic advantage conferred by the administration of α2 agonists other than lessening exposure to other potentially har ...
prescribing information for INVOKAMET
... impairment, alcoholism, or heart failure; or in patients who will be administered intra-arterial iodinated contrast. Re-evaluate eGFR 48 hours after the imaging procedure, and restart INVOKAMET if renal function is stable. Surgery and Other Procedures: Withholding of food and fluids during surgical ...
... impairment, alcoholism, or heart failure; or in patients who will be administered intra-arterial iodinated contrast. Re-evaluate eGFR 48 hours after the imaging procedure, and restart INVOKAMET if renal function is stable. Surgery and Other Procedures: Withholding of food and fluids during surgical ...
Clinical management of progressive myopia
... (in the CONTROL study, near fixation disparities were neutralized), as well as best correctable distance acuity, etc. Although changes in refractive error offer a more valid measure of progression in MFSCL than in the case of OrthoK, the purchase of an IOLmaster or LENSTAR is strongly recommended to ...
... (in the CONTROL study, near fixation disparities were neutralized), as well as best correctable distance acuity, etc. Although changes in refractive error offer a more valid measure of progression in MFSCL than in the case of OrthoK, the purchase of an IOLmaster or LENSTAR is strongly recommended to ...
Tinea capitis guidelines 2014 - British Association of Dermatologists
... based on the best data available when the document was prepared. It is recognized that under certain conditions it may be necessary to deviate from the guidelines and that the results of future studies may require some of the recommendations herein to be changed. Failure to adhere to these guideline ...
... based on the best data available when the document was prepared. It is recognized that under certain conditions it may be necessary to deviate from the guidelines and that the results of future studies may require some of the recommendations herein to be changed. Failure to adhere to these guideline ...
AusPAR: Pomalidomide - Therapeutic Goods Administration
... last two decades, has converted what was once a disease with median overall survival (OS) of 3 years, to now a chronic disease capable of long term control, often for 7 years or more. However, almost all patients will relapse after an initial response. Various definitions for relapsed and refractory ...
... last two decades, has converted what was once a disease with median overall survival (OS) of 3 years, to now a chronic disease capable of long term control, often for 7 years or more. However, almost all patients will relapse after an initial response. Various definitions for relapsed and refractory ...
[product name]ô - Medicines.org.au
... term therapy for the prevention of relapse (acute exacerbations) in chronic schizophrenic patients. First episode psychosis. In a 6-week double blind, parallel group, active controlled study in first admission, newly diagnosed schizophrenic patients (N=183, risperidone=99, haloperidol=84) risperidon ...
... term therapy for the prevention of relapse (acute exacerbations) in chronic schizophrenic patients. First episode psychosis. In a 6-week double blind, parallel group, active controlled study in first admission, newly diagnosed schizophrenic patients (N=183, risperidone=99, haloperidol=84) risperidon ...
Full Report - NIHR Journals Library
... are prescribed simvastatin 40 mg/day, then simvastatin 80 mg/day, atorvastatin 80 mg/day and rosuvastatin 40 mg/day would be considered cost-effective compared with simvastatin 40 mg/day in individuals with ACS. Simvastatin 80 mg/day is not well tolerated because of the high incidence rates of less ...
... are prescribed simvastatin 40 mg/day, then simvastatin 80 mg/day, atorvastatin 80 mg/day and rosuvastatin 40 mg/day would be considered cost-effective compared with simvastatin 40 mg/day in individuals with ACS. Simvastatin 80 mg/day is not well tolerated because of the high incidence rates of less ...
Medical Policy Title: Treatment of Hyperhidrosis
... One of the larger RCTs was published in 2007. (12) This study was an industry-sponsored multicenter double-blind, placebo-controlled efficacy and safety study of botulinum toxin type A in patients with persistent bilateral primary axillary hyperhidrosis. Enrollment criteria included a resting sweat ...
... One of the larger RCTs was published in 2007. (12) This study was an industry-sponsored multicenter double-blind, placebo-controlled efficacy and safety study of botulinum toxin type A in patients with persistent bilateral primary axillary hyperhidrosis. Enrollment criteria included a resting sweat ...
American Acupuncturist_V64_Summer13
... With the untimely passing of Al Stone, DAOM, LAc on May 24th, the field of acupuncture and Oriental medicine lost a dedicated and revered pioneer, teacher, practitioner and advocate. Al’s accomplishments and reputation for excellence will long be felt and appreciated. Over the years, Al dedicated a ...
... With the untimely passing of Al Stone, DAOM, LAc on May 24th, the field of acupuncture and Oriental medicine lost a dedicated and revered pioneer, teacher, practitioner and advocate. Al’s accomplishments and reputation for excellence will long be felt and appreciated. Over the years, Al dedicated a ...
Recombinant human growth hormone for the treatment of growth
... he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘ ...
... he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘ ...
For Trials Journal
... limited use of 1,4-BD in the UK and therefore hereafter we will use the term GHB/GBL to refer to these compounds. They are used recreationally predominately for their stimulant and prosexual effects, although some individuals use them for their sedative effects and/or to help “come down” after use o ...
... limited use of 1,4-BD in the UK and therefore hereafter we will use the term GHB/GBL to refer to these compounds. They are used recreationally predominately for their stimulant and prosexual effects, although some individuals use them for their sedative effects and/or to help “come down” after use o ...
Transdermal Nicotine Maintenance Attenuates the
... testing, and assessment for adequate venous access. In addition, a battery of psychiatric instruments was used to screen for psychiatric disorders. Volunteers were excluded from participating if they had an abnormal ECG, hypertension, significant risk factors for heart disease, a history of seizure ...
... testing, and assessment for adequate venous access. In addition, a battery of psychiatric instruments was used to screen for psychiatric disorders. Volunteers were excluded from participating if they had an abnormal ECG, hypertension, significant risk factors for heart disease, a history of seizure ...
Is Bevacizumab Effective in Inhibiting the Growth of Recurrent
... significant reduction in conjunctival vascularization. Decrease in conjunctival injection was observed until 2 weeks for the group who received 2.5mg of Bevacizumab, and until 3 weeks for the group that received the highest dose of Bevacizumab, 3.75mg. At later points, conjunctival hyperemia increas ...
... significant reduction in conjunctival vascularization. Decrease in conjunctival injection was observed until 2 weeks for the group who received 2.5mg of Bevacizumab, and until 3 weeks for the group that received the highest dose of Bevacizumab, 3.75mg. At later points, conjunctival hyperemia increas ...
Study Protocol Phase II clinical trial testing the safety and efficacy of
... combination of anxiolysis (reduction in fear and anxiety), euphoria, feelings of interpersonal closeness and facilitated recall for past events would seem to have the potential to maximize or amplify the benefits of psychotherapeutic interventions. MDMA primarily acts as a monoamine releaser, as wel ...
... combination of anxiolysis (reduction in fear and anxiety), euphoria, feelings of interpersonal closeness and facilitated recall for past events would seem to have the potential to maximize or amplify the benefits of psychotherapeutic interventions. MDMA primarily acts as a monoamine releaser, as wel ...
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
... aware of bad side of or risk associated with snoring. Secondly: those who are aware of snoring very few of them agree to perform sleep study at any sleep centre which is not only tedious and time consuming but also very much expensive. Besides this, available mechanical treatment is also very expens ...
... aware of bad side of or risk associated with snoring. Secondly: those who are aware of snoring very few of them agree to perform sleep study at any sleep centre which is not only tedious and time consuming but also very much expensive. Besides this, available mechanical treatment is also very expens ...
Cough Suppressant and Pharmacologic
... that may increase cough clearance) in patients with disorders in which thickened or accumulated mucus contributes to morbidity. In the previous evidence-based guideline, these types of cough therapy were termed nonspecific, to differentiate them from therapy-specific for a particular disease/disorde ...
... that may increase cough clearance) in patients with disorders in which thickened or accumulated mucus contributes to morbidity. In the previous evidence-based guideline, these types of cough therapy were termed nonspecific, to differentiate them from therapy-specific for a particular disease/disorde ...
FLOVENT HFA (fluticasone propionate) Inhalation Aerosol
... of FLOVENT HFA in minimizing HPA dysfunction may be expected only when recommended dosages are not exceeded and individual patients are titrated to the lowest effective dose. A relationship between plasma levels of fluticasone propionate and inhibitory effects on stimulated cortisol production has b ...
... of FLOVENT HFA in minimizing HPA dysfunction may be expected only when recommended dosages are not exceeded and individual patients are titrated to the lowest effective dose. A relationship between plasma levels of fluticasone propionate and inhibitory effects on stimulated cortisol production has b ...
Placebo-controlled study
![](https://commons.wikimedia.org/wiki/Special:FilePath/Cebocap.jpg?width=300)
Placebo-controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham ""placebo"" treatment which is specifically designed to have no real effect. Placebos are most commonly used in blinded trials, where subjects do not know whether they are receiving real or placebo treatment. Often, there is also a further ""natural history"" group that does not receive any treatment at all.The purpose of the placebo group is to account for the placebo effect, that is, effects from treatment that do not depend on the treatment itself. Such factors include knowing one is receiving a treatment, attention from health care professionals, and the expectations of a treatment's effectiveness by those running the research study. Without a placebo group to compare against, it is not possible to know whether the treatment itself had any effect.Patients frequently show improvement even when given a sham or ""fake"" treatment. Such intentionally inert placebo treatments can take many forms, such as a pill containing only sugar, a surgery where nothing efficacious is actually done (just an incision and sometimes some minor touching or handling of the underlying structures), or a medical device (such as an ultrasound machine) that is not actually turned on. Also, due to the body's natural healing ability and statistical effects such as regression to the mean, many patients will get better even when given no treatment at all. Thus, the relevant question when assessing a treatment is not ""does the treatment work?"" but ""does the treatment work better than a placebo treatment, or no treatment at all?"" As one early clinical trial researcher wrote, ""the first object of a therapeutic trial is to discover whether the patients who receive the treatment under investigation are cured more rapidly, more completely or more frequently, than they would have been without it.""p.195 More broadly, the aim of a clinical trial is to determine what treatments, delivered in what circumstances, to which patients, in what conditions, are the most effective.Therefore, the use of placebos is a standard control component of most clinical trials, which attempt to make some sort of quantitative assessment of the efficacy of medicinal drugs or treatments. Such a test or clinical trial is called a placebo-controlled study, and its control is of the negative type. A study whose control is a previously tested treatment, rather than no treatment, is called a positive-control study, because its control is of the positive type.Government regulatory agencies approve new drugs only after tests establish not only that patients respond to them, but also that their effect is greater than that of a placebo (by way of affecting more patients, by affecting responders more strongly, or both). As a result, ""placebo-controlled studies often are designed in such a way that disadvantages the placebo condition"".